info@synchemia.com | sales@synchemia.com 
9766925136 
Cobimetinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Cobimetinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso Impurity 1 CAS NO:NAchemically represented as (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(piperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso Impurity 1.We supply Cobimetinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143444 |
| CAS No | NA |
| Mol.F. | C17H18N6O3 |
| Mol.Wt. | 354.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143445 |
| CAS No | NA |
| Mol.F. | C9H6N6O |
| Mol.Wt. | 214.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143446 |
| CAS No | NA |
| Mol.F. | C8H7N2O4S |
| Mol.Wt. | 227.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143447 |
| CAS No | NA |
| Mol.F. | C35H31N7O5 |
| Mol.Wt. | 629.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143448 |
| CAS No | NA |
| Mol.F. | C26H28N6O3 |
| Mol.Wt. | 472.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143449 |
| CAS No | NA |
| Mol.F. | C26H28N6O3 |
| Mol.Wt. | 472.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143450 |
| CAS No | NA |
| Mol.F. | C17H21N5O |
| Mol.Wt. | 311.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143451 |
| CAS No | NA |
| Mol.F. | C25H26N6O4 |
| Mol.Wt. | 474.5 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143452 |
| CAS No | NA |
| Mol.F. | C25H26N6O4 |
| Mol.Wt. | 474.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143453 |
| CAS No | NA |
| Mol.F. | C26H28N6O4 |
| Mol.Wt. | 488.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143454 |
| CAS No | NA |
| Mol.F. | C26H28N6O4 |
| Mol.Wt. | 488.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143455 |
| CAS No | NA |
| Mol.F. | C26H25N5O4 |
| Mol.Wt. | 471.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143456 |
| CAS No | NA |
| Mol.F. | C26H26N6O4 |
| Mol.Wt. | 486.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143457 |
| CAS No | NA |
| Mol.F. | C26H20ClN5O3 |
| Mol.Wt. | 485.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143458 |
| CAS No | NA |
| Mol.F. | C19H26Cl2N4O4 |
| Mol.Wt. | 445.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143459 |
| CAS No | NA |
| Mol.F. | C26H28N4O7 |
| Mol.Wt. | 508.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
